Kyongbo Pharmaceutical Co Ltd (214390) — Free Cash Flow Generation Index
Kyongbo Pharmaceutical Co Ltd (214390) has a Free Cash Flow Generation Index of -7.69x as of March 2026. Free cash flow of ₩-13.76 Billion represents -8% of operating cash flow (₩1.79 Billion). Explore Kyongbo Pharmaceutical Co Ltd (214390) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Kyongbo Pharmaceutical Co Ltd Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for Kyongbo Pharmaceutical Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see Kyongbo Pharmaceutical Co Ltd (214390) cash conversion ratio.
Annual Free Cash Flow Generation for Kyongbo Pharmaceutical Co Ltd (2014–2025)
Year-by-year Free Cash Flow Generation Index for Kyongbo Pharmaceutical Co Ltd. Check Kyongbo Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.58x | ₩-34.16 Billion | ₩7.46 Billion | ₩41.61 Billion | ▲ +94.8% |
| 2024 | -87.35x | ₩-13.03 Billion | ₩149.12 Million | ₩13.18 Billion | ▼ -6914.5% |
| 2023 | -1.25x | ₩-6.03 Billion | ₩4.84 Billion | ₩10.88 Billion | ▼ -312.5% |
| 2022 | -0.30x | ₩-3.06 Billion | ₩10.13 Billion | ₩13.18 Billion | ▼ -1425.3% |
| 2021 | -0.02x | ₩-355.61 Million | ₩17.97 Billion | ₩18.32 Billion | ▼ -104.9% |
| 2020 | 0.40x | ₩8.36 Billion | ₩20.80 Billion | ₩12.44 Billion | ▲ +2154.5% |
| 2019 | 0.02x | ₩421.97 Million | ₩23.67 Billion | ₩23.25 Billion | ▼ -97.5% |
| 2017 | 0.71x | ₩18.41 Billion | ₩25.81 Billion | ₩7.40 Billion | ▲ +220.1% |
| 2016 | 0.22x | ₩5.64 Billion | ₩25.33 Billion | ₩19.68 Billion | ▲ +104.1% |
| 2015 | -5.43x | ₩-23.02 Billion | ₩4.24 Billion | ₩27.26 Billion | ▼ -2589.5% |
| 2014 | -0.20x | ₩-3.24 Billion | ₩16.04 Billion | ₩19.28 Billion | — |